Gastrointestinal Stromal Tumours: Etiology, Pathology and Clinical Management

Investigation of the regulation of cell growth, differentiation and death by signalling pathways has led to a greater understanding of how alterations in these pathways play a critical role in the development of some cancers, and has opened new opportunities for their treatment. In the present revie...

Full description

Saved in:
Bibliographic Details
Main Authors: Martin E Blackstein, Pierre Dubé, Jonathan A Fletcher, Oliver R Keller, Margaret Knowling, Richard Létourneau, Donald Morris, Robert Riddell, Stewart Rorke, Carol J Swallow, Canadian Advisory Committee on GIST
Format: Article
Language:English
Published: Wiley 2004-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/2004/238037
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567021099810816
author Martin E Blackstein
Pierre Dubé
Jonathan A Fletcher
Oliver R Keller
Margaret Knowling
Richard Létourneau
Donald Morris
Robert Riddell
Stewart Rorke
Carol J Swallow
Canadian Advisory Committee on GIST
author_facet Martin E Blackstein
Pierre Dubé
Jonathan A Fletcher
Oliver R Keller
Margaret Knowling
Richard Létourneau
Donald Morris
Robert Riddell
Stewart Rorke
Carol J Swallow
Canadian Advisory Committee on GIST
author_sort Martin E Blackstein
collection DOAJ
description Investigation of the regulation of cell growth, differentiation and death by signalling pathways has led to a greater understanding of how alterations in these pathways play a critical role in the development of some cancers, and has opened new opportunities for their treatment. In the present review, results with the prototype drug of this class, imatinib (Gleevec, Glivec [formerly STI571]; Novartis, Switzerland), in metastatic gastrointestinal stromal tumours are presented. The present review originated from a conference of the authors held in Montreal, Quebec in June 2003, under the sponsorship of Novartis.
format Article
id doaj-art-1b0ec018271f48a59964ca2614839313
institution Kabale University
issn 0835-7900
language English
publishDate 2004-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology
spelling doaj-art-1b0ec018271f48a59964ca26148393132025-02-03T01:02:27ZengWileyCanadian Journal of Gastroenterology0835-79002004-01-0118Suppl B3B8B10.1155/2004/238037Gastrointestinal Stromal Tumours: Etiology, Pathology and Clinical ManagementMartin E Blackstein0Pierre Dubé1Jonathan A Fletcher2Oliver R Keller3Margaret Knowling4Richard Létourneau5Donald Morris6Robert Riddell7Stewart Rorke8Carol J Swallow9Canadian Advisory Committee on GIST10Mount Sinai Hospital, Toronto, Ontario, CanadaCentre Hospitalier Maisonneuve-Rosemont, Montreal, Quebec, CanadaBrigham and Women’s Hospital, Boston, Massachusetts, USAOttawa Regional Cancer Centre, Ottawa, Ontario, CanadaBritish Columbia Cancer Agency – Vancouver Cancer Clinic, Vancouver, British Columbia, CanadaCentre Hospitalier de l’Université de Montréal, Montreal, Quebec, CanadaTom Baker Cancer Centre, Calgary, Alberta, CanadaMount Sinai Hospital, Toronto, Ontario, CanadaDr H Bliss Murphy Cancer Centre, St John’s, Newfoundland, CanadaMount Sinai Hospital, Toronto, Ontario, CanadaMount Sinai Hospital, Toronto, Ontario, CanadaInvestigation of the regulation of cell growth, differentiation and death by signalling pathways has led to a greater understanding of how alterations in these pathways play a critical role in the development of some cancers, and has opened new opportunities for their treatment. In the present review, results with the prototype drug of this class, imatinib (Gleevec, Glivec [formerly STI571]; Novartis, Switzerland), in metastatic gastrointestinal stromal tumours are presented. The present review originated from a conference of the authors held in Montreal, Quebec in June 2003, under the sponsorship of Novartis.http://dx.doi.org/10.1155/2004/238037
spellingShingle Martin E Blackstein
Pierre Dubé
Jonathan A Fletcher
Oliver R Keller
Margaret Knowling
Richard Létourneau
Donald Morris
Robert Riddell
Stewart Rorke
Carol J Swallow
Canadian Advisory Committee on GIST
Gastrointestinal Stromal Tumours: Etiology, Pathology and Clinical Management
Canadian Journal of Gastroenterology
title Gastrointestinal Stromal Tumours: Etiology, Pathology and Clinical Management
title_full Gastrointestinal Stromal Tumours: Etiology, Pathology and Clinical Management
title_fullStr Gastrointestinal Stromal Tumours: Etiology, Pathology and Clinical Management
title_full_unstemmed Gastrointestinal Stromal Tumours: Etiology, Pathology and Clinical Management
title_short Gastrointestinal Stromal Tumours: Etiology, Pathology and Clinical Management
title_sort gastrointestinal stromal tumours etiology pathology and clinical management
url http://dx.doi.org/10.1155/2004/238037
work_keys_str_mv AT martineblackstein gastrointestinalstromaltumoursetiologypathologyandclinicalmanagement
AT pierredube gastrointestinalstromaltumoursetiologypathologyandclinicalmanagement
AT jonathanafletcher gastrointestinalstromaltumoursetiologypathologyandclinicalmanagement
AT oliverrkeller gastrointestinalstromaltumoursetiologypathologyandclinicalmanagement
AT margaretknowling gastrointestinalstromaltumoursetiologypathologyandclinicalmanagement
AT richardletourneau gastrointestinalstromaltumoursetiologypathologyandclinicalmanagement
AT donaldmorris gastrointestinalstromaltumoursetiologypathologyandclinicalmanagement
AT robertriddell gastrointestinalstromaltumoursetiologypathologyandclinicalmanagement
AT stewartrorke gastrointestinalstromaltumoursetiologypathologyandclinicalmanagement
AT caroljswallow gastrointestinalstromaltumoursetiologypathologyandclinicalmanagement
AT canadianadvisorycommitteeongist gastrointestinalstromaltumoursetiologypathologyandclinicalmanagement